Altered serotonin innervation patterns in the forebrain of monkeys treated with (±)3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery

Journal of Neuroscience

Volumn 19, Issue 12, 1999, Pages 5096-5107

  Hatzidimitriou, George ^a   McCann, Una D ^b   Ricaurte, George A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

5 HT axon; Amphetamines; Methylenedioxymethamphetamine; Neurotoxicity; Regenerati on; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; SEROTONIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FOREBRAIN; INNERVATION; MALE; MONKEY; NERVE ENDING; NERVE FIBER; NERVE FIBER REGENERATION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; RAPHE NUCLEUS; REINNERVATION; SEROTONIN BRAIN LEVEL;

EID: 0033564773     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-12-05096.1999     Document Type: Article

References (49)

1. Adelekan M, Adlaf E, Alkott A, Banaag C, Bem P (1997) Epidemiology and social context of amphetamine-type stimulant use. In: Amphetamine-type stimulants: a report from the WHO meeting on amphetamines, MDMA and other psychostimulants, Geneva, pp 12-15. Programme on Substance Abuse, Division of Mental Health and Prevention of Substance Abuse. World Health Organization.
2. Axt K, Mamounas L, Molliver M (1994) Structural features of amphetamine neurotoxicity in the brain. In: Amphetamine and its analogs: neuropsychopharmacology, toxicology and abuse (Cho A, Segal D, eds), pp 315-370. New York: Academic.
3. Azmitia EC, Gannon PJ (1983) The ultrastructural localization of serotonin immunoreactivity in myelinated and unmyelinated axons within the medial forebrain bundle of the rat and monkey. J Neurosci 3:2083-2090.
4. Azmitia EC, Gannon PJ (1986) The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. Adv Neurol 43:407-468.
5. +2-dependent toxicity linked to release. Brain Res 510:97-103.
6. 3H]paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther 242:911-916.
7. Battaglia G, Yeh SY, DeSouza EB (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29:269-274.
8. Baum RM (1985) New variety of street drugs poses growing problem. Chem Eng News 63:7-16.
9. Bjorklund A, Wiklund L (1980) Mechanisms of regrowth of the bulbospinal serotonin system following 5,6-dihydroxytryptamine-induced axotomy: biochemical correlates. Brain Res 191:109-127.
10. Bjorklund A, Wiklund L, Descarries L (1979) Regeneration and plasticity of central serotonergic neurons: a review. J Physiol (Lond) 77:247-255.
11. Commins DL, Vosmer G, Virus R, Woolverton W, Schuster C, Seiden L (1987) Biochemical and histological evidence that methylenedioxym-ethylamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241:338-345.
12. De Souza EB, Battaglia G, Insel T (1990) Neurotoxic effects of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies. Ann NY Acad Sci 600:682-698.
13. Doblin R (1989) Risk assessment: the FDA and MDMA research. In: Ecstasy: the MDMA story (Eisner B, ed), pp 163-170. Berkeley, CA: Ronin.
14. Emmers R, Akert K (1963) A stereotaxic atlas of the brain of the squirrel monkey (Saimiri sciureus). Madison, WI: University of Wisconsin.
15. Fischer CA, Hatzidimitriou G, Katz JL, Ricaurte GA (1995) Reorganization of ascending serotonin axon projections in animals previously exposed to the recreational drug 3,4-methylenedioxymethamphetamine. J Neurosci 15:5476-5485.
16. Frankfurt M, Azmitia E (1984) Regeneration of serotonergic fibers in the rat hypothalamus following unilateral 5,7-dihydroxytryptamine injection. Brain Res 298:273-282.
17. Frankfurt M, Beaudet A (1987) Ultrastructural organization of regenerated serotonin axons in the dorsomedial hypothalamus of the adult rat. J Neurocytol 16:799-809.
18. Gergen JA, MacLean PD (1962) A stereotaxic atlas of the squirrel monkey's brain (Saimiri sciureus). United States Department of Health Education and Welfare, Public Health Service Publication 933.
19. Hornung JP, Fritschy JM, Tork I (1990) Distribution of two morphologically distinct subsets of serotoninergic axons in the cerebral cortex of the marmoset. J Comp Neurol 297:165-181.
20. Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB (1989) 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. J Pharmacol Exp Ther 249:713-720.
21. Jacobs BL, Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72:165-229.
22. Johnston L, Bachman J, O'Malley P (1996) National survey results on drug use from the monitoring the future study. National Institutes on Drug Abuse, 1975-1994. Vol 2: College students and young adults. NIH Publication No. 96-4027.
23. Johnston L, Bachman J, O'Malley P (1998) National survey results on drug use from the monitoring the future study. National Institutes on Drug Abuse, 1975-1995. Vol 2: College students and young adults. NIH Publication 98-4346.
24. Kosofsky B, Molliver M (1987) The serotoninergic innervation of the cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse 1:153-168.
25. Lavoie B, Parent A (1990) Immunohistochemical study of the serotoninergic innervation of the basal ganglia of the squirrel monkey. J Comp Neurol 299:1-16.
26. Lew R, Sabol KE, Chou C, Vosmer GL, Richards J, Seiden LS (1996) Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies J Pharmacol Exp Ther 276:855-865.
27. Mamounas LA, Molliver ME (1991) Dual serotonergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J Comp Neurol 314:558-586.
28. Mamounas LA, Blue ME, Siuciak JA, Altar CA (1995) BDNF promotes the survival of sprouting serotonergic axons in rat brain. J Neurosci 15:7929-7939.
29. McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994a) Serotonin neurotoxicity after (±)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans. Neuropsychopharmacology 10:129-138.
30. McCann UD, Hatzidimitriou G, Ridenour A, Fisher C, Yuan J, Katz J, Ricaurte GA (1994b) Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated. J Pharmacol Exp Ther 269:792-798.
31. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet 352:1433-1437.
32. Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn EG, Wilson MA (1990) Neurotoxicity of MDMA and related compounds: anatomic studies. Ann NY Acad Sci 600:640-664.
33. O'Hearn EG, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788-2803.
34. Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, Langston JW (1988a) (±)3,4-Methylenedioxymethamphetamine (MDMA) selectively damages central serotonergic neurons in non-human primates. JAMA 260:51-55.
35. Ricaurte GA, DeLanney LE, Irwin I, Langston JW (1988b) Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res 446:165-168.
36. Ricaurte GA, Martello AL, Katz JL, Martello MB (1992) Lasting effects of (±)3,4-methylenedioxymethamphetamine on central serotonergic neurons in non-human primates: neurochemical observations. J Pharmacol Exp Ther 261:616-622.
37. Sabol KE, Lew R, Richards JB, Vosmer GL, Seiden LS (1996) Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: synaptosomal uptake and tissue concentrations. J Pharmacol Exp Ther 276:846-854.
38. Saunders N (1995) Ecstasy and the dance culture. London: Nicholas Saunders.
39. Scanzello CR, Hatzidimitriou G, Martello AL, Katz JL, Ricaurte GA (1993) Serotonergic recovery after (±)3,4-(methylenedioxy) methamphetamine injury: observations in rats. J Pharmacol Exp Ther 264:1484-1491.
40. Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1-7.
41. Schmidt CJ, Taylor VL (1987) Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem Pharmacol 36:4095-4102.
42. Schneider GE (1973) Early lesions of the superior colliculus: factors affecting the formation of abnormal retinal projections. Brain Behav Evol 8:73-109.
43. Slikker W, Ali SF, Scallet C, Frith CH, Newport GD, Bailey JR (1988) Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Toxicol Appl Pharmacol 94:448-457.
44. Stone DM, Stahl DS, Hanson GL, Gibb JW (1986) The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine on monoaminergic systems in the rat brain. Eur J Pharmacol 128:41-48.
45. Wiklund L, Bjorklund A, Nobin A (1978) Regeneration of serotonin neurons in the rat brain after 5,6-dihydroxytryptamine-induced axotomy. Ann NY Acad Sci 305:370-384.
46. Wilson MA, Ricaurte GA, Molliver ME (1989) Distinct morphological classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine. Neuroscience 28:121-137.
47. Wilson MA, Mamounas LA, Fasman KA, Axt KJ, Molliver ME (1993) Reactions of 5-HT neurons to drugs of abuse: neurotoxicity and plasticity. NIDA Research Monograph 136:155-187.
48. Woolverton WL, Ricaurte GA, Forno LS, Seiden LS (1989) Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res 486:73-78.
49. Zaczek R, Battaglia G, Gulp S, Appel NM, Contrera JF, De Souza EB (1990) Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity, and time course data. J Pharmacol Exp Ther 253:104-112.